Gilead Sciences Change in Other Assets decreased by 90.2% to $36.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 75.3%, from $146.00M to $36.00M. Over 3 years (FY 2021 to FY 2025), Change in Other Assets shows an upward trend with a 94.9% CAGR.
Large swings are usually related to the timing of prepayments for services or long-term supply agreements.
This captures the net change in miscellaneous operating assets not classified as receivables or inventory, such as prepa...
This is typically a smaller component of cash flow for most large-cap technology firms unless they are securing long-term supply capacity.
cf_change_in_other_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.00M | $15.00M | $25.00M | $20.00M | $10.00M | -$42.00M | -$58.00M | -$26.00M | -$40.00M | -$5.00M | $37.00M | $19.00M | $57.00M | $146.00M | -$12.00M | -$81.00M | $368.00M | $36.00M |
| QoQ Change | — | +350.0% | +66.7% | -20.0% | -50.0% | -520.0% | -38.1% | +55.2% | -53.8% | +87.5% | +840.0% | -48.6% | +200.0% | +156.1% | -108.2% | -575.0% | +554.3% | -90.2% |
| YoY Change | — | — | — | — | +266.7% | -380.0% | -332.0% | -230.0% | -500.0% | +88.1% | +242.3% | +147.5% | >999% | — | -132.4% | -526.3% | +545.6% | -75.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.